(Q44758871)

6 December 2017

title

Hydroxyurea treatment for sickle cell disease: impact on haematopoietic stem cell transplantation's outcome (English)

1 reference

6 December 2017

0 references

1 reference

Brachet C

1

1 reference

6 December 2017

Azzi N

2

1 reference

6 December 2017

Demulder A

3

1 reference

6 December 2017

Devalck C

4

1 reference

6 December 2017

Gourdin A

5

1 reference

6 December 2017

Gulbis B

6

1 reference

6 December 2017

Klein A

7

1 reference

6 December 2017

Le PQ

8

1 reference

6 December 2017

Loop M

9

1 reference

6 December 2017

Sariban E

10

1 reference

6 December 2017

Ferster A

11

1 reference

6 December 2017

language of work or name

English

0 references

publication date

1 April 2004

1 reference

Bone Marrow Transplantation

6 December 2017

published in

1 reference

6 December 2017

volume

33

1 reference

6 December 2017

issue

8

1 reference

6 December 2017

page(s)

799-803

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.bmt.1704443

6 December 2017

exact match

0 references

cites work

Mortality in sickle cell disease. Life expectancy and risk factors for early death.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704443

Stem cell transplantation for sickle cell disease: can we reduce the toxicity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704443

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704443

Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704443

Hydroxyurea and sickle cell anemia. Clinical utility of a myelosuppressive "switching" agent. The Multicenter Study of Hydroxyurea in Sickle Cell Anemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704443

Three-year follow-up of hydroxyurea treatment in severely ill children with sickle cell disease. The French Study Group on Sickle Cell Disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704443

Preliminary report of a toxicity study of hydroxyurea in sickle cell disease. French Study Group on Sickle Cell Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704443

Five years of experience with hydroxyurea in children and young adults with sickle cell disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704443

Use of hydroxyurea in children ages 2 to 5 years with sickle cell disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704443

Effect of hydroxyurea on mortality and morbidity in adult sickle cell anemia: risks and benefits up to 9 years of treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704443

Bone marrow transplant for sickle cell disease--the dilemma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704443

Pain in sickle cell disease. Rates and risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704443

7 January 2021

Causes and outcomes of the acute chest syndrome in sickle cell disease. National Acute Chest Syndrome Study Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704443

7 January 2021

Bone marrow transplantation in five children with sickle cell anaemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704443

7 January 2021

Haematopoietic stem cell transplantation for sickle cell anaemia: the first 50 patients transplanted in Belgium

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704443

7 January 2021

Clinical and hematologic effects of hydroxyurea in children with sickle cell anemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704443

7 January 2021

Second marrow transplants for graft failure in patients with thalassemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704443

7 January 2021

Identifiers

DOI

10.1038/SJ.BMT.1704443

1 reference

Dimensions Publication ID

6 December 2017

1015542834

0 references

1 reference